Cost-utility Study of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01590420|
Recruitment Status : Unknown
Verified May 2012 by Camila Furtado Rizzi, Associação Fundo de Incentivo à Pesquisa.
Recruitment status was: Recruiting
First Posted : May 3, 2012
Last Update Posted : May 3, 2012
|Condition or disease||Intervention/treatment||Phase|
|Obstructive Sleep Apnea Syndrome||Device: CPAP S8- Scape / Resmed||Phase 4|
OSA is highly prevalent in Sao Paulo city, Brazil. It is associated with significant comorbidities. The cost-utility study is important to (1) support decision-making on health policies, (2) to incorporate new technologies, (3) implementation of preventive programs and policy development assistance in the medical field.
Probably CPAP treatment in the long-term, will improve health, physical and mental state, and especially, reduces spending on public health, demonstrating cost-utility.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1000 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Cost-utility Study of CPAP Treatment in Obstructive Sleep Apnea Patients|
|Study Start Date :||March 2011|
|Actual Primary Completion Date :||March 2011|
|Estimated Study Completion Date :||March 2014|
Experimental: CPAP treatment
1000 patients with 3-years CPAP treatment after a PSG titration
Device: CPAP S8- Scape / Resmed
The pressure for treatment is according to PSG titration
- costs of medical events post CPAP treatment [ Time Frame: 3 years ]To evaluate the health satuts costs post-CPAP treatment.
- Number of hospitalizations [ Time Frame: 3 years ]
- Changes in medications [ Time Frame: 3 years ]
- Costs relative to CPAP treatment [ Time Frame: 3 years ]To evaluate the influence of CPAP device on directs health costs
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01590420
|Contact: Camila F Rizzi, PhD||+55 (11) firstname.lastname@example.org|
|Contact: Dalva Poyares, PhD||+55 (11) email@example.com|
|Associação Fundo de Incentivo à Pesquisa||Recruiting|
|Sao Paulo, Brazil, 04024-002|
|Contact: Camila F Rizzi, PhD +55 (11) 85555049 firstname.lastname@example.org|
|Principal Investigator: Camila F Rizzi, PhD|
|Principal Investigator:||Camila F Rizzi, PhD||Federal University of São Paulo|
|Study Chair:||Dalva Poyares, PhD||Federal University of São Paulo|
|Study Director:||Sergio Tufik, PhD||Federal University of São Paulo|
|Study Chair:||Marcos F Bosi, PhD||Federal University of São Paulo|